Nakade Yusuke, Toyama Tadashi, Furuichi Kengo, Kitajima Shinji, Ohkura Noriyuki, Sagara Akihiro, Shinozaki Yasuyuki, Hara Akinori, Kitagawa Kiyoki, Shimizu Miho, Iwata Yasunori, Oe Hiroyasu, Nagahara Mikio, Horita Hiroshi, Sakai Yoshio, Kaneko Shuichi, Wada Takashi
Clinical Laboratory, Kanazawa University Hospital, Kanazawa, Japan.
Clin Exp Nephrol. 2014 Oct;18(5):763-9. doi: 10.1007/s10157-013-0920-7. Epub 2013 Dec 15.
Although the cardiorenal relationship in chronic kidney disease has been investigated, information about the lung-kidney relationship is limited. Here, we investigated the impact of kidney function and urinary protein excretion on pulmonary dysfunction.
The data from pulmonary function tests and kidney function (estimated glomerular filtration rate [eGFR] and urinary protein) between 1 April 2005 and 30 June 2010 were selected from our laboratory database. Data were classified into 4 categories according to eGFR and proteinuria. Category 1, eGFR ≥60 ml/min/1.73 m(2) and urinary protein <0.3 g/gCr; category 2, eGFR <60 ml/min/1.73 m(2) and urinary protein <0.3 g/gCr; category 3, eGFR ≥60 ml/min/1.73 m(2) and urinary protein ≥0.3 g/gCr; and category 4, eGFR <60 ml/min/1.73 m(2) and urinary protein ≥0.3 g/gCr. Pulmonary function data were evaluated according to these 4 categories.
A total of 133 participants without major respiratory disease, abnormal computed tomography and smoking history were enrolled. Hemoglobin (Hb)-adjusted percentage carbon monoxide diffusing capacity (%DLCO) in category 4 (46.2 ± 7.5) and category 2 (63.6 ± 17.8) were significantly lower than in category 1 (75.8 ± 18.9) (P < 0.05). In addition, Hb-adjusted %DLCO was weakly correlated with eGFR in participants with urinary protein <0.3 g/gCr (R = 0.30, P = 0.001). Hb-adjusted %DLCO was strongly correlated with eGFR in participants with urinary protein ≥0.3 g/gCr (R = 0.81, P < 0.001). Other pulmonary function test markers (percentage (%) vital capacity, % forced expiratory volume in one second (FEV1), FEV1/forced vital capacity, % total lung capacity, and % residual volume) were not significantly different between categories.
This study suggests that decreased eGFR is associated with decreased %DLCO in proteinuric patients.
尽管慢性肾脏病中心脏与肾脏的关系已得到研究,但有关肺与肾脏关系的信息有限。在此,我们研究了肾功能和尿蛋白排泄对肺功能障碍的影响。
从我们的实验室数据库中选取2005年4月1日至2010年6月30日期间肺功能测试及肾功能(估算肾小球滤过率[eGFR]和尿蛋白)的数据。根据eGFR和蛋白尿将数据分为4类。第1类,eGFR≥60 ml/min/1.73 m²且尿蛋白<0.3 g/gCr;第2类,eGFR<60 ml/min/1.73 m²且尿蛋白<0.3 g/gCr;第3类,eGFR≥60 ml/min/1.73 m²且尿蛋白≥0.3 g/gCr;第4类,eGFR<60 ml/min/1.73 m²且尿蛋白≥0.3 g/gCr。根据这4类对肺功能数据进行评估。
共纳入133名无重大呼吸系统疾病、计算机断层扫描异常及吸烟史的参与者。第4类(46.2±7.5)和第2类(63.6±17.8)经血红蛋白(Hb)校正的一氧化碳弥散量百分比(%DLCO)显著低于第1类(75.8±18.9)(P<0.05)。此外,尿蛋白<0.3 g/gCr的参与者中,经Hb校正的%DLCO与eGFR呈弱相关(R = 0.30,P = 0.001)。尿蛋白≥0.3 g/gCr的参与者中,经Hb校正的%DLCO与eGFR呈强相关(R = 0.81,P<0.001)。其他肺功能测试指标(肺活量百分比(%)、一秒用力呼气量百分比(FEV1)、FEV1/用力肺活量、肺总量百分比和残气量百分比)在各分类之间无显著差异。
本研究表明,在蛋白尿患者中,eGFR降低与%DLCO降低相关。